Deferasirox desensitization

Given that deferasirox is the only oral iron chelator approved for pediatric use in the United States and that maculopapular rash is a known adverse reaction of the medication, it leaves pediatric patients with deferoxamine as their only other option for iron chelation therapy. Deferasirox desensiti...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The journal of allergy and clinical immunology in practice (Cambridge, MA) MA), 2016-01, Vol.4 (1), p.171-172
Hauptverfasser:	Bruner, Karen E., MD, White, Kevin M., MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Aged Allergens - immunology Allergy and Immunology Benzoates - immunology Benzoates - therapeutic use Blood Transfusion Blood transfusions Chelation therapy Child Desensitization, Immunologic - methods Drug Eruptions - immunology Drug Eruptions - therapy Epidemics FDA approval Female Humans Immunoglobulins Internal Medicine Iron Chelating Agents - therapeutic use Iron Overload - drug therapy Iron Overload - etiology Male Patients Pediatrics Postoperative Complications - drug therapy Triazoles - immunology Triazoles - therapeutic use Withholding Treatment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!